HOME >> BIOLOGY >> NEWS
Nuclear medicine aids early diagnosis of pulmonary anthrax

Reston, VA - A nuclear medicine procedure that has the potential to safely pinpoint even the smallest amounts of infected tissue has received preliminary approval for a clinical trial in the diagnosis of inhalation anthrax before symptoms become apparent. A report on this possible breakthrough will appear in the Newsline section of the December issue of The Journal of Nuclear Medicine, available on December 19. The Newsline article can be found at: http://www.snm.org/pdf/newslinecurr.pdf

The JNM Newsline reports that the Food and Drug Administration (FDA) has approved a protocol for a clinical trial to assess the efficacy of a 99mTc-labeled monoclonal antibody in imaging early-stage inhalation anthrax infection.

According to the representatives of the company that has developed the monoclonal antibody, the technique offers the unique ability to detect the earliest stages of involvement, before any other laboratory or radiographic diagnostic tests can detect the presence of infection and well before the more serious symptoms of inhalation anthrax infection are apparent. Newsline reports that the technique promises not only to identify and begin treatment for patients in the earliest stages of infection but to provide a means by which patients can be definitively identified as disease free and taken off long-term wide-spectrum antibiotic treatment.

According to Newsline, the protocol, developed by Robert Bridwell, MD, Associate Professor of Nuclear Medicine and Radiology and the Uniformed Services University of the Health Sciences (Bethesda, MD) and staff physician at Walter Reed Army Medical Center (WRAMC; Washington, DC), is designed to identify asymptomatic patients who have experienced credible exposure to anthrax spores. Information from Bridwell obtained by SNM after the article went to press, indicated that all patients exposed will be assessed and that for ethical reasons there
'"/>

Contact: Karen Lubieniecki
karenlub@aol.com
703-683-0357
Society of Nuclear Medicine
11-Dec-2001


Page: 1 2 3

Related biology news :

1. Society of Nuclear Medicines 51st Annual Meeting June 19-23, 2004
2. Image of the Year announced by Society of Nuclear Medicine
3. Nuclear waste disposal: A safer solution?
4. Heavy Traffic At The Nuclear Pore: How Proteins And RNA Leave The Cell Nucleus
5. Nuclear Safer Than Coal?
6. Probing the surface of white blood cells to enhance immune system medicine
7. From science fiction to reality: Nanomedicine brings fresh hope to the medical world
8. Annals of internal medicine tip sheet, July 20, 2004
9. Germans must research the history of reproductive medicine during the Nazi era
10. New public policy & aging report highlights facts and fiction about anti-aging medicine
11. K-State business researchers to help with major study on food supply veterinary medicine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nuclear medicine aids early diagnosis pulmonary anthrax

(Date:7/30/2014)... black truffle uses reversible epigenetic processes to regulate its ... ,methylome, - a picture of the genome regulation taking ... access journal Genome Biology and illustrates how ... and ,jumping genes,. The authors say this may shed ... controlled. , Black truffles (Tuber melanosporum), also known as ...
(Date:7/30/2014)... deep-sea octopus protected and tended her eggs until they ... July 30, 2014 in the open-access journal PLOS ... Research Institute and colleagues. , Octopuses typically have a ... protect and take care of their fertilized eggs until ... for 1 to 3 months, but little is known ...
(Date:7/30/2014)... effects of climate change on the world,s animal ... factors, according to a new paper by a ... of Queensland, and other organizations. The authors claim ... the point when it comes to climate change. ... scientists focus on the "direct" threats of changing ...
Breaking Biology News(10 mins):How black truffles deal with the jumpers in their genome 2Deep-sea octopus has longest-known egg-brooding period 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2
(Date:7/31/2014)... 31, 2014 North Shore Towers, a luxury ... with GI Energy, one of the nation’s leading combined heating ... upgrade of its 43-year-old CHP system. The original CHP system ... effort to extend the life of the plant, GI Energy ... electrical and heat recovery equipment, while maintaining continuous operation of ...
(Date:7/31/2014)... , July 31, 2014 Research and ... "Global Genomics Market 2014-2018" report to their offering. ... Genomics is the study of the genetic material or ... a strong basis for the discovery and development of ... diseases or health conditions. Genomics is supported by three ...
(Date:7/31/2014)... Senomyx , Inc. (NASDAQ: SNMX ... technologies to discover, develop, and commercialize novel flavor ... industries, today reported financial results for the second ... with $33.6 million in cash and highly liquid ... Senomyx achieved another important milestone with the regulatory ...
(Date:7/31/2014)... DIEGO and SHENZHEN, China ... announced today the purchase of an Irys™System ... organization. BGI selected BioNano,s platform to enable comprehensive exploration ... improved assemblies for various organisms of interest, including those ... will partner together to develop new methods for multiplexing ...
Breaking Biology Technology:North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4
Cached News: